Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Association between Development of Dementia and Use of Benzodiazepines: A Systematic Review and Meta-Analysis.

Lucchetta RC, da Mata BPM, Mastroianni PC.

Pharmacotherapy. 2018 Oct;38(10):1010-1020. doi: 10.1002/phar.2170. Epub 2018 Sep 6.

PMID:
30098211
2.

The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study.

Tapiainen V, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen AM.

Acta Psychiatr Scand. 2018 Aug;138(2):91-100. doi: 10.1111/acps.12909. Epub 2018 May 31.

PMID:
29851063
3.

Association Between Psychotropic and Cardiovascular Iatrogenic Alerts and Risk of Hospitalizations in Elderly People Treated for Dementia: A Self-Controlled Case Series Study Based on the Matching of 2 French Health Insurance Databases.

Zerah L, Boddaert J, Leperre-Desplanques A, Bonnet-Zamponi D, Verny M, Deligne J, Boelle PY.

J Am Med Dir Assoc. 2017 Jun 1;18(6):549.e1-549.e13. doi: 10.1016/j.jamda.2017.02.001. Epub 2017 Mar 18.

PMID:
28330633
4.

Association between high cumulative dose of benzodiazepine in Chinese patients and risk of dementia: a preliminary retrospective case-control study.

Chan TT, Leung WC, Li V, Wong KW, Chu WM, Leung KC, Ng YZ, Kai YG, Shea YF, Chang SR, Chu LW.

Psychogeriatrics. 2017 Sep;17(5):310-316. doi: 10.1111/psyg.12239. Epub 2017 Feb 1.

PMID:
28145025
5.

Benzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims Data.

Biétry FA, Pfeil AM, Reich O, Schwenkglenks M, Meier CR.

CNS Drugs. 2017 Mar;31(3):245-251. doi: 10.1007/s40263-016-0404-x.

PMID:
28078633
6.

Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease.

Saarelainen L, Tolppanen AM, Koponen M, Tanskanen A, Sund R, Tiihonen J, Hartikainen S, Taipale H.

J Am Med Dir Assoc. 2017 Jan;18(1):87.e15-87.e21. doi: 10.1016/j.jamda.2016.09.019. Epub 2016 Nov 12.

PMID:
27847263
7.

Benzodiazepine Use Attenuates Cortical β-Amyloid and is Not Associated with Progressive Cognitive Decline in Nondemented Elderly Adults: A Pilot Study Using F18-Florbetapir Positron Emission Tomography.

Chung JK, Nakajima S, Shinagawa S, Plitman E, Chakravarty MM, Iwata Y, Caravaggio F, Pollock BG, Gerretsen P, Graff-Guerrero A; Alzheimer's Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2016 Nov;24(11):1028-1039. doi: 10.1016/j.jagp.2016.04.013. Epub 2016 May 4.

PMID:
27538351
8.

Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis.

Imfeld P, Bodmer M, Jick SS, Meier CR.

Drug Saf. 2015 Oct;38(10):909-19. doi: 10.1007/s40264-015-0319-3.

PMID:
26123874
9.

Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease.

Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S.

Int Clin Psychopharmacol. 2015 Jul;30(4):202-8. doi: 10.1097/YIC.0000000000000080.

PMID:
26011780
10.

An increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control study.

Shih HI, Lin CC, Tu YF, Chang CM, Hsu HC, Chi CH, Kao CH.

Medicine (Baltimore). 2015 May;94(17):e809. doi: 10.1097/MD.0000000000000809. Erratum in: Medicine (Baltimore). 2015 Jun;94(24):1.

11.

[Taking benzodiazepine is associated with an increased risk of Alzheimer disease].

Steurer J.

Praxis (Bern 1994). 2014 Dec 10;103(25):1530. doi: 10.1024/1661-8157/a001871. German. No abstract available.

PMID:
25491057
12.

Benzodiazepine use and risk of Alzheimer's disease: case-control study.

Billioti de Gage S, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, Pariente A, Bégaud B.

BMJ. 2014 Sep 9;349:g5205. doi: 10.1136/bmj.g5205.

13.

Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings.

Gallini A, Andrieu S, Donohue JM, Oumouhou N, Lapeyre-Mestre M, Gardette V.

Eur Neuropsychopharmacol. 2014 Jan;24(1):95-104. doi: 10.1016/j.euroneuro.2013.09.003. Epub 2013 Sep 17.

14.

Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment-dementia converters measured by positron emission tomography with [¹¹C]DAA1106.

Yasuno F, Kosaka J, Ota M, Higuchi M, Ito H, Fujimura Y, Nozaki S, Takahashi S, Mizukami K, Asada T, Suhara T.

Psychiatry Res. 2012 Jul 30;203(1):67-74. doi: 10.1016/j.pscychresns.2011.08.013. Epub 2012 Aug 11.

PMID:
22892349
15.

Psychotropic medication burden and factors associated with antipsychotic use: an analysis of a population-based sample of community-dwelling older persons with dementia.

Rhee Y, Csernansky JG, Emanuel LL, Chang CG, Shega JW.

J Am Geriatr Soc. 2011 Nov;59(11):2100-7. doi: 10.1111/j.1532-5415.2011.03660.x. Epub 2011 Sep 23.

16.

Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study.

Kröger E, van Marum R, Souverein P, Egberts T.

Drugs Aging. 2010 Aug 1;27(8):663-75. doi: 10.2165/11538230-000000000-00000.

PMID:
20658794
17.

Influence of medications and diagnoses on fall risk in psychiatric inpatients.

Lavsa SM, Fabian TJ, Saul MI, Corman SL, Coley KC.

Am J Health Syst Pharm. 2010 Aug;67(15):1274-80. doi: 10.2146/ajhp090611.

PMID:
20651318
18.

The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data.

Wu CS, Wang SC, Chang IS, Lin KM.

Am J Geriatr Psychiatry. 2009 Jul;17(7):614-20. doi: 10.1097/JGP.0b013e3181a65210.

PMID:
19546656
19.

[Mortality rates in patients with Alzheimer's disease treated with atypical neuroleptic drugs].

Vilalta-Franch J, Lopez-Pousa S, Garre-Olmo J, Turon-Estrada A, Pericot-Nierga I.

Rev Neurol. 2008 Feb 1-15;46(3):129-34. Spanish.

20.

Supplemental Content

Loading ...
Support Center